Harvard Bioscience Inc.

NASDAQ:HBIO  
2.76
0.00 (0.00%)
4:01:46 PM EDT: $2.76 0.00 (0.00%)
Earnings Announcements

Harvard Bioscience Announces Third Quarter 2022 Financial Results

Published: 11/08/2022 21:35 GMT
Harvard Bioscience Inc. (HBIO) - Harvard Bioscience Announces Third Quarter 2022 Financial Results.
Harvard Bioscience Inc - Qtrly Revenue $26.9 Million Versus $29.7 Million.
Harvard Bioscience Inc - Qtrly GAAP Loss per Share $0.08.
Harvard Bioscience Inc - Qtrly Adjusted Loss per Share $0.01.
Further Company Coverage: Hbioo ((reuters.
Briefs@thomsonreuters.
Com;)).
Revenue is expected to be $30.4 Million
Adjusted EPS is expected to be $0.05

Next Quarter Revenue Guidance is expected to be $28.95 Million
Next Quarter EPS Guidance is expected to be $0.04

More details on our Analysts Page.